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Context: It is unknown whether leptin and peptide YY (PYY) influence changes in resting 
energy expenditure (REE), independently of fat mass (FM) and fat-free mass (FFM) in addition 
to changes in other energy expenditure (EE) components during weight loss. 
Objective: The objective of the study was to examine the relationships between leptin, PYY, and 
body composition with different EE components before and after weight loss and whether 
changes in leptin and PYY were associated with differences in predicted vs measured REE after 
the intervention. 
Design: This was a randomized controlled design. 
Setting: The study was conducted in a laboratory. 
Participants: Participants were ninety-three overweight/obese postmenopausal women (aged 
58.1 ± 4.8 y; body mass index 32.1 ± 4.3 kg/m2). 
Intervention: Interventions included a 6-month caloric restriction diet alone or caloric 
restriction diet+resistance training. 
Main Outcome Measures: Body composition (dual energy x-ray absorptiometry), REE 
(indirect calorimetry), total EE (TEE; doubly labeled water), and fasting leptin and total PYY 
before and after weight loss were measured. 
Results: Both interventions yielded significant decreases in weight, FFM, REE, and leptin, 
whereas a significant time × group interaction was noted for FM (greater decrease in FM in the 
diet+resistance training group) (P < .05 for all outcomes). No significant differences in TEE, 
physical activity EE, and PYY were noted between baseline and after the intervention. Age, 
FFM, leptin, and PYY were the best predictors of baseline REE (R2 = 0.77; P = .0001), whereas 
age, FFM, and FM were associated with REE after the intervention (R2 = 0.88; P = .0001). The 
same predictors, except for leptin, were significantly related to TEE at baseline (R2 = 0.70; P = 
.0001) and after the intervention (R2 = 0.29; P = .0001), whereas only PYY was a significant 
predictor of physical activity EE at baseline and after the intervention. Changes in FM and leptin 
accounted for 27% of the variance in ΔREE (P = .0001). Greater predicted vs measured REE 
was noted after the intervention (P = .02). However, Δ leptin and ΔPYY were not significant 
predictors of the differences between postintervention measurement and predicted REE. 
Conclusions: Δ Leptin and ΔFM were strong contributors to changes in REE. However, Δ leptin 
and ΔPYY were not significant predictors of the differences between predicted and measured 
REE after the intervention. 
 




Abbreviations: CI, confidence interval; EE, energy expenditure; FFM, fat-free mass; FM, fat mass; PAEE, 
physical activity EE; PYY, peptide YY; REE, resting EE; 1-RM, 1-maximum repetition; TEE, total EE. 
 
Several approaches have been used in an attempt to induce sustainable weight loss in obese 
individuals. Among them is the combination of caloric restriction and resistance exercise, which 
can promote weight loss in obese individuals while preserving fat-free mass (FFM) (1, 2). 
However, a well-documented effect of weight loss is the decrease in resting energy expenditure 
(REE) (3–5). A recent systematic review reported that the average magnitude in REE reduction 
is −15.4 kcal/kg of weight loss (4) when assessed during the dynamic phase of weight loss in 
obese individuals. This review also reported that shorter weight loss trials (duration of 2–6 
weeks) and caloric restriction only interventions resulted in greater mean decreases in REE 
relative to weight loss compared with longer interventions (>6 wk) as well as other types of 
weight-loss interventions (exercise only, pharmaceutical, surgery, and combination of exercise + 
caloric restriction) (4). It is often assumed that this reduction in REE is commensurate to changes 
in weight, presumably because of the strong relationship between body composition and total EE 
(TEE) (6). However, there is converging evidence that weight reduction may result in greater 
than predicted decreases in REE during a weight loss intervention (5, 7–14), which may be 
sustained after the end of the intervention (5, 10, 13, 15, 16). Keys and colleagues (3) were 
among the first to document significantly greater-than-predicted reductions in REE during the 
dynamic phase of weight loss, after weight loss, and during weight recovery. These results are 
further supported by recent findings, reporting greater-than-predicted decreases in REE in 
response to severe and sustained energy restriction (5, 7) and less stringent weight-loss 
conditions (8–14), with these decreases lasting up to 6 years after the end of the intervention 
(13, 15, 16). Leibel et al (10) also demonstrated that decreases in REE were on average 10%–
15% greater during the dynamic phase of weight loss vs a 10% weight-loss maintenance period. 
Collectively, because successful long-term weight loss requires the matching of energy intake to 
energy expenditure (EE), this implies that even relatively small decreases in REE may 
predispose weight-reduced individuals to weight regain (5, 8–14). Furthermore, decreases in 
REE that are greater than that predicted with equations (5, 7–14) may be maintained over time 
(15, 16), even after weight regain to levels greater than baseline (5). 
 
Given that changes in body mass do not seem to account for all the variance in REE reductions 
that occur after weight loss (5, 12–16), other factors have been previously investigated. It has 
been shown that thyroid function and catecholamine excretion (17), as well as changes in leptin 
(18, 19), among others, provide an independent contribution to changes in energy metabolism 
during weight loss. Furthermore, providing obese participants with recombinant leptin after 
weight loss attenuated some of the disproportionate decline in TEE observed during reduced 
weight maintenance (20). 
 
Some reports suggest that peptide YY (PYY) might also be related to energy metabolism. Sloth 
et al (21) were among the first to show that TEE had a tendency to increase after the injection of 
PYY 3–36. Recent studies have however reported conflicting results; noting positive associations 
between PYY with postprandial EE (22) and REE (23) and negative associations between PYY 
and REE (24). 
 
Thus, leptin and PYY are seemingly implicated in fluctuations of REE and TEE. However, it 
remains to be determined whether PYY is a significant correlate of REE, TEE, and physical 
activity energy expenditure (PAEE) before and after weight loss. Furthermore, it is unknown 
whether changes in these peptides influence changes in energy metabolism after weight loss, 
including the greater-than-predicted decreases in REE. This study assessed the effects of caloric 
restriction + resistance training and caloric restriction alone interventions on changes in leptin, 
PYY, and body composition as well as different EE components (REE, TEE, and PAEE). 
Furthermore, we evaluated the strength of the associations between leptin, PYY and body 
composition [fat mass (FM) and FFM] with EE components before and after weight loss. We 
also assessed the strength of the associations between changes in leptin, PYY, and body 
composition with those of different EE components during the dynamic phase of weight loss. 
Lastly, we assessed whether changes in REE are greater than predicted and whether changes in 
leptin and PYY are associated with the potential differences in the predicted vs measured REE 
postintervention. 
 




Participants were recruited from the Montréal Ottawa New Emerging Team project. Study 
methodology details can be found in a report by Brochu et al (25). This study was designed to 
investigate, using a randomized controlled design, the impact of a 6-month caloric restriction and 
12-month weight maintenance on the following: 1) metabolic, inflammation, and hormonal 
profiles, 2) body composition, 3) EE, and 4) psychosocial profiles in overweight/obese 
postmenopausal women. Participants were recruited through newspaper advertisements, and data 
were collected from 2003 to 2006. Participants were randomly assigned in a 1:2 fashion to a 
caloric restriction diet alone or a caloric restriction diet + resistance training because the women 
who completed the 6-month diet alone were also asked to participate in a 12-month follow-up 
with or without the resistance training program. The participants who completed all required 
measurements during the 6-month intervention are presented herein (n = 65 for the diet alone 
group; n = 28 for the diet + resistance training group). The inclusion criteria, which are published 
elsewhere (21), were as follows: 1) body mass index 25 kg/m2 or greater, 2) cessation of 
menstruation for more than 1 year and an FSH level of 30 IU/L or greater, 3) sedentary (<2 h/wk 
of structured physical activity), 4) nonsmoker, 5) low to moderate alcohol consumption (fewer 
than two drinks per day), 6) no known inflammatory disease, and 7) no use of hormone 
replacement therapy. After a physical examination and biological testing, all participants had no 
history or evidence of the following: 1) cardiovascular disease, peripheral vascular disease, or 
stroke; 2) diabetes (75 g oral glucose tolerance test); 3) known renal and liver disease; 4) asthma 
requiring therapy or plasma cholesterol greater than 8 mmol/L; 5) systolic and diastolic blood 
pressures greater than 160 and 100 mm Hg, respectively; 6) history of alcohol or drug abuse; 7) 
history of inflammation disease or cancer; 8) orthopedic limitations; 9) weight fluctuation of ±2 
kg in the last 6 months, 10) untreated thyroid or pituitary disease; and 11) medications that could 
affect cardiovascular function and/or metabolism. The Université de Montréal Ethics Committee 
approved the study and informed consent was obtained from all participants. 
 
Caloric restriction intervention 
 
Participants took part in a 6-month weight-loss program aimed at reducing weight by 10%, as 
previously described (25). For 4 weeks prior to and after the weight-loss intervention, we 
minimized weight variations within a ±2 kg range, at which time all outcome measurements 
were performed. To determine the level of caloric restriction, baseline REE was multiplied by a 
physical activity factor of 1.4, which is equivalent to a sedentary state (26), and 800 kcal was 
then subtracted from this result (27). However, this caloric restriction was reduced when the 
calculated daily energy requirements were below 1000 kcal (in these cases, the mean reduction 
was 633 kcal). Prescribed energy intake during the intervention ranged from 1000 to 1790 kcal. 
Diet macronutrient composition was standardized to 55%, 30%, and 15% of energy intake from 
carbohydrates, lipids, and proteins, respectively. Participants met with the study dietitian weekly 
to review their prescribed diet and dietary recommendations and to discuss compliance 
throughout the weight-loss trial. During these meetings, the dietitian reviewed the diet restriction 
with participants and provided them with measures to help adherence to the dietary prescription. 
Participants were also invited to meet with the dietitian bimonthly for nutritional education 
classes (60–90 min each). The average rate of participation in these classes were 28.1% ± 30.2% 
and 29.9% ± 28.8% in the diet only and diet + resistance training groups, respectively [P = NS, 
as previously reported (25)]. During the weight-loss intervention, participants in the diet only 




The 6-month resistance-training program included four progressive phases that were performed 
weekly on 3 nonconsecutive days. Phase 1 included an introduction to training (3 wk, 15 
repetitions or ∼65% of maximum, two to three sets per exercise with 90–120 sec between sets), 
whereas phases 2–4 saw a progressive increase in the intensity and duration of the exercises 
performed (phase 2: 5 wk, 12 repetitions, or ∼70% of maximum, two to three sets per exercise 
with 90 sec between sets; phase 3: 9 wk, 8–10 repetitions, or ∼75%–80% of maximum, two to 
four sets per exercise with 120–180 sec between sets; phase 4: 8 wk, 10–12 repetitions, or 
∼70%–75% of maximum, three to four sets per exercise with 60–90 sec between sets). Each 
training session started with 10 minutes of low-intensity warm-up on the treadmill (ie, walking). 
The resistance-training program included leg press, chest press, lateral pull-downs, shoulder 
press, arm curls, and triceps extensions. An exercise physiologist supervised all training sessions, 
and he/she adjusted the workload, if necessary, to maintain the number of repetitions prescribed. 
All participants performed a 1-maximum repetition (1-RM) test every 4 weeks to adapt the 
workload accordingly. If none of the trials yielded a 1-RM, the Wathan equation was used to 




Weight was measured to the nearest 0.1 kg on a calibrated scale (Balance Industrielle Montréal), 
and height was obtained with a standard stadiometer (Perspective Enterprises). Total FM and 
FFM were measured using dual-energy x-ray absorptiometry (General Electric Lunar Prodigy; 
software version 6.10.019). The measured intraclass coefficient correlation of FM and FFM 
measurements with this technique was 0.99 in 18 volunteers. 
 
Resting energy expenditure 
 
REE was measured after a 12-hour fast by indirect calorimetry for 40 minutes (10 min 
acclimatization period and 30 min of measurements) while the participants were fasting. 
Concentrations of CO2 and O2 were measured using the ventilated hood technique with a 
SensorMedics δ Track II (Datex-Ohmeda). The intraclass correlation for REE measured with this 
technique, which was determined using test-retest conditions, is 0.921 (n = 19). 
 
Physical activity energy expenditure and TEE 
 
TEE was measured over 10 days with the doubly labeled water technique, as previously 
described (29). PAEE was calculated with the following equation: PAEE = (TEE × 0.90) − REE. 
PAEE is therefore defined as energy use not related to the energy cost of food ingestion and 
digestion and to the energy cost of REE. 
 
Calculation of predicted REE after intervention 
 
A stepwise multiple regression analysis was used to determine the best predictors of baseline 
REE in this cohort. The independent predictors entered into the model were age, FM, FFM, 
height, leptin, and PYY at baseline. FFM, age, leptin, and PYY met the entry criteria of P ≤ .05 
and were used to compute the following equation: REE (kilocalories per day) = 485.08 + 
(23.18*FFM) + (−6.35*age) + (2.14*leptin) + (0.70*PYY), with an R2 of 76.8% and a SE of the 
estimate of 94 kcal/d. This equation was then used to predict REE after the intervention. The 
calculated mean REE with this equation at baseline was essentially the same as that measured at 
baseline (REE: 1312 ± 191 vs 1312 ± 168 kcal/d; P = 1.00), thus indicating a strong validity of 
this equation to estimate REE after intervention. 
 
Calculation of compliance to the caloric restriction intervention and energy imbalance 
 
A ratio between expected and actual changes in body energy stores was calculated. As such, 
compliance was calculated based on the prescribed caloric restriction at baseline, but was 
adjusted for changes in TEE, measured with doubly labeled water, at baseline and after the 
intervention [ie, ([TEE with doubly labeled water (baseline) − prescribed energy intake 
(baseline)] + [TEE with doubly labeled water (after intervention) − prescribed energy intake 
(baseline)]/2)*180 d]. We then divided actual changes in body energy stores using equivalents of 
9400 kcal/kg of FM loss and 1200 kcal/kg of FFM loss (14) by the total calculated energy 
deficit. The average daily energy imbalance was also determined by multiplying the change in 
FM and FFM by their respective energy densities of 9400 and 1200 kcal/kg (14) and then 




Venous blood samples were collected to measure fasting total PYY and fasting leptin levels. An 
iv catheter was inserted into an antecubital vein of the nondominant arm. All samples were 
placed into tubes containing EDTA. Blood samples were then centrifuged at 3500 rpm at 4°C 
and stored at −80°C until assayed. Leptin and total PYY (includes both PYY 1–36 and 3–36) 
were assayed in duplicates with commercially available ELISA kits [human leptin ELISA kit-
EZHL-80SK and human PYY (total) ELISA kit-EZHPYYT-66K; Millipore Corp]. In our 
laboratory, the intrakit coefficient of variation for leptin and PYY were 3.4% and 7.1%, 




Statistical analyses were performed using SPSS (version 17.0; SPSS Inc). Repeated-measures 
ANOVA with intervention (diet only or diet + resistance training) as the between-subject 
variable evaluated changes between baseline and postintervention values for FM, FFM, REE, 
TEE, PAEE, leptin, and PYY as well as the differences between predicted and measured REE 
after the intervention. Secondary analyses of these same outcomes corrected for the degree of 
caloric restriction were also performed. Pearson correlations were performed between body 
composition and hormone variables with EE components at baseline and postintervention as well 
as between the changes in these variables of interest. Forward stepwise linear regressions were 
then used to determine the overall contribution of age, height, FM, FFM, leptin, and PYY to 
REE, PAEE, and TEE at baseline and after the intervention as well as the contribution of ΔFM, 
ΔFFM, Δ leptin, and ΔPYY to ΔREE, ΔPAEE, and ΔTEE in response to the intervention. Effects 




Participant characteristics prior to and after weight loss are presented in Table 1. Both 
interventions yielded significant decreases in weight and FFM, whereas a significant time × 
group interaction was noted for FM (ie, greater decrease in FM in the diet + resistance training 
group) (25). The interventions also led to significant decreases in REE in both groups, whereas 
no significant differences in TEE and PAEE were noted (27). Fasting absolute (nanograms per 
milliliter) and relative (nanograms per milliliter per kilogram of fat mass) leptin levels were 
significantly lower after the intervention compared with baseline, whereas no significant 
differences in fasting PYY levels were noted between baseline and after the intervention. Fasting 
PYY was, however, greater in the diet + resistance training group compared with the diet only 
group, independently of the intervention time. After correcting for the degree of caloric 
restriction, the changes in weight, FFM, leptin, and REE were no longer significant, which is 
supported by significant interactions between these outcomes and the degree of caloric restriction 
(P < .05 for all outcomes). Correlational analyses further support these results, in which 
significant associations were noted between Δweight (r = −0.23; P = .03), ΔFFM (r = −0.23; P = 
.02), Δ leptin (r = −0.21; P = .04), and ΔREE (r = −0.25; P = .02) with the degree of caloric 
restriction. The calculated compliance to the caloric restriction for the entire intervention was 
19% and was positively associated with ΔREE (r = 0.49, P < .0001) and Δweight (r = 0.85, P < 
.0001). Additionally, the magnitude of energy imbalance was related to ΔREE (r = 0.49, P < 
.0001) and Δweight (r = 0.9, P < .0001). Baseline fasting leptin and PYY were associated with 
Δweight (leptin: r = 0.27; P = .01; PYY: r = −0.21; P = .05) and ΔFFM (leptin: r = 0.39; P = 
.0001; PYY: r = −0.26; P = .01). Δ leptin was also associated with Δweight (r = 0.64; P = .0001), 
ΔFM (r = 0.64; P = .0001) and ΔFFM (r = 0.21; P = .04), whereas no significant associations 
were observed between ΔPYY with changes in weight or body composition (results not shown). 
 
Table 1. Participants Characteristics Assessed at Baseline and After the Weight-Loss 
Intervention According to Intervention Group (Caloric Restriction Only, n = 65; Caloric 
Restriction + Resistance Training, n = 28) 
 Baseline 
After 
Intervention Mean Difference 
Body weight, kga,b        
Caloric restriction only  83.5 (14.5)  78.6 (13.8)  −4.8 (4.6)  
Caloric restriction + resistance training  81.5 (11.2)  74.8 (10.9)  −6.7 (4.5)  
FM, kga,c        
Caloric restriction only  37.8 (8.8)  33.9 (9.2)  −3.9 (3.6)  
Caloric restriction + resistance training  37.9 (7.3)  31.8 (8.1)  −6.1 (4.1)  
FFM, kga,b        
Caloric restriction only  45.6 (7.3)  44.7 (6.2)  −0.9 (2.4)  
Caloric restriction + resistance training  43.6 (5.5)  43.0 (4.2)  −0.5 (2.3)  
REE, kcal/db,d        
Caloric restriction only  1318 (208)  1262 (206)  −56 (92) or −11.4 (20.2) kcal/kg of weight loss  
Caloric restriction + resistance training  1298 (146)  1230 (154)  −67 (110) or−10.1 (24.4) kcal/kg of weight loss  
TEE, kcal/dd        
Caloric restriction only  2475 (380)  2408 (368)  −67 (364) or−13.7 (79.1) kcal/kg of weight loss  
Caloric restriction + resistance training  2528 (366)  2412 (339)  −117 (331) or−17.3 (73.6) kcal/kg of weight loss  
PAEE, kcal/dd        
Caloric restriction only  909 (281)  905 (293)  −4 (334) or−0.8 (72.6) kcal/kg of weight loss  
Caloric restriction + resistance training  978 (242)  940 (272)  −38 (301) or−5.7 (66.9) kcal/kg of weight loss  
Leptin, ng/mLb        
Caloric restriction only  38.7 (17.0)  31.2 (16.7)  −7.4 (13.3)  
Caloric restriction + resistance training  35.1 (13.5)  24.8 (16.2)  −10.3 (12.2)  
Leptin, ng/ml · kg of fat massb        
Caloric restriction only  1.0 (0.3)  0.9 (0.4)  −0.1 (0.3)  
Caloric restriction + resistance training  0.9 (0.3)  0.7 (0.4)  −0.2 (0.3)  
PYY, pg/mLe        
Caloric restriction only  96.2 (47.6)  100.9 (51.0)  4.7 (31.5)  
Caloric restriction + resistance training  120.2 (38.6)  124.5 (36.1)  4.4 (31.4)  
Values are expressed as means (SD). 
a Data are adapted from Brochu et al (25). 
b Significant difference between baseline and after the intervention (P < .05). 
c Significant time × group interaction (P < .05). 
d Data are adapted from St Onge et al (27). 
e Significant difference between intervention groups (P < .05). 
 
Table 2 presents the correlations between body composition and hormone variables with EE 
components. REE and TEE were positively correlated with FM, FFM, and leptin at baseline and 
after the intervention. TEE was also negatively associated with PYY at baseline and after the 
intervention. PAEE was positively associated with FM at baseline and negatively associated with 
PYY at both baseline and after the intervention. 
 
Table 2. Correlations Between Body Composition Variables, Leptin, and PYY With EE 
Components 
 FM, kg FFM, kg Leptin, ng/mL PYY, pg/mL 
REE          
Baseline  r = 0.61; P = .0001  r = 0.84; P = .0001  r = 0.41; P = .0001  r = −0.05; P = .64  
After intervention  r = 0.67; P = .0001  r = 0.83; P = .0001  r = 0.40; P = .0001  r = 0.02; P = .83  
TEE          
Baseline  r = 0.52; P = .0001  r = 0.56; P = .0001  r = 0.40; P = .0001  r = −0.37; P = .0001  
After intervention  r = 0.41; P = .0001  r = 0.43; P = .0001  r = 0.22; P = .04  r = 0.25; P = .02  
PAEE          
Baseline  r = 0.22; P = .04  r = 0.10; P = .34  r = 0.21; P = .05  r = −0.42; P = .0001  
After intervention  r = 0.01; P = .92  r = −0.07; P = .50  r = −0.02; P = .84  r = −0.29; P = .004  
 
Table 3 presents the significant independent predictors of REE, TEE, and PAEE at baseline and 
after the intervention. The combination of age, FFM, leptin, and PYY was the best predictor of 
baseline REE, whereas the combination of age, FFM, and FM predicted the greatest amount of 
variance in REE after the intervention. The combination of age, FFM, FM, and PYY was the best 
predictor of baseline TEE, whereas age, PYY, and FFM were significant predictors of this 
variable after weight loss. Age and PYY were significant predictors of PAEE at baseline, 
whereas only PYY was a significant predictor of PAEE after the intervention. 
 
Significant associations were noted between ΔREE with ΔFM (r = 0.48; P = .0001) and Δ leptin 
(r = 0.47; P = .0001). These results are further supported by regression analyses, suggesting that 
the combination of ΔFM and Δ leptin accounted for approximately 27% of the variance in ΔREE 
[R2 = 0.27; β = 7.69; 95% confidence interval (CI) 1.8–13.5 for FM and β = 2.04; 95% CI 0.3–
3.8 for leptin; P = .0001]. ΔFFM was significantly correlated with ΔTEE (r = 0.24; P = .02) and 
was the only variable found to be a significant predictor of ΔTEE (R2 = 0.06; β = 35.23; 95% CI 
5.4–65.0 P = .02). Changes in none of the variables were significantly associated with ΔPAEE 
(results not shown). 
 
Significantly greater predicted vs measured REE values were observed after weight loss (Figure 
1). This significant effect disappeared after correcting for the degree of caloric restriction. The 
degree of energy restriction was positively associated with the difference between predicted and 
measured REE postintervention (r = 0.30; P = .004), thus suggesting that participants with the 
greatest degree of energy restriction had greater decreases in their actual REE, compared with 
predicted values postintervention. However, the calculated compliance to the energy restriction 
(r = 0.03, P = .77) and energy imbalance (r = 0.04; P = .66) were not associated with greater-
than-predicted decreases in REE. Lastly, Δ leptin and ΔPYY were not associated with the 
differences between postintervention measured and predicted REE (leptin: R2 = 0.00; β = .07; 
95% CI −1.4–1.6; P = .93; PYY: R2 = 0.01; β = −.27; 95% CI −0.9–0.4; P = .40). 
 
Table 3. The Amount of Variance (R2) and the Standardized Regression Coefficient (β) for the 
Significant Predictors of REE, TEE, and PAEE at Baseline and After Weight Loss (n = 93) 
Dependent Variable Model Significant Predictor(s) R2 β 95% CI for β 
Baseline REE  1  FFM  0.70  .84a  20.2–26.6  
  2  FFM+  0.73  .85a  20.8–27.0  
    Age    −.16b  −10.9 to−2.1  
  3  FFM+  0.74  .81a  19.4–25.8  
    Age+    −.15b  −10.2 to−1.6  
    Leptin    .14c  0.3–3.0  
  4  FFM+  0.77  .83a  20.1–26.3  
    Age+    −.16b  −10.5 to−2.2  
    Leptin+    .18b  0.8–3.5  
    PYY    .17b  0.26–1.1  
Baseline PAEE  1  PYY  0.18  −.42a  −3.6 to−1.4  
  2  PYY+  0.22  −.41a  −3.5 to−1.3  
    Age    −.21c  −22.3 to−1.5  
Baseline TEE  1  FFM  0.31  .56a  20.9–39.9  
  2  FFM+  0.39  .59a  23.1–41.1  
    Age    −.29b  −35.6 to−10.1  
  3  FFM+  0.45  .54a  20.6–38.2  
    Age+    −.27b  −33.5 to−9.0  
    PYY    −.25b  −3.3 to−0.7  
  4  FFM+  0.48  .41a  11.8–32.8  
    Age+    −.24b  −31.1 to−6.9  
    PYY+    −.23b  −3.1 to−0.6  
    FM    .22c  1.4–18.4  
Post-weight-loss REE  1  FFM  0.70  .83a  24.0–31.7  
  2  FFM+  0.76  .67a  18.1–26.5  
    FM    .30a  3.7–9.1  
  3  FFM+  0.78  .71a  19.7–27.8  
    FM+    .27a  3.2–8.4  
    Age    −.16b  −10.4 to−2.4  
Post-weight-loss PAEE  1  PYY  0.09  −.29b  −2.9 to −0.6  
Post-weight-loss TEE  1  FFM  0.19  .43a  15.4–38.8  
  2  FFM+  0.25  .48a  18.2–41.1  
    Age    −.25b  −32.1 to −4.8  
  3  FFM+  0.29  .46a  17.4–39.9  
    Age+    −.23c  −30.8 to −3.9  
    PYY    −.20c  −2.8 to −0.2  
a P < .001. 
b P < .01. 
c P < .05. 
 
 
Figure 1. Measured and predicted REE at baseline and after the intervention. 




This is the first study to include all components of EE (REE, TEE, and PAEE), which were 
objectively assessed with gold standard measurements before and after weight loss using two 
different interventions in obese postmenopausal women. Furthermore, this study assessed the 
potential predictors of these components of EE before, during, and after weight loss. Our results 
indicate that age, FFM, leptin, and PYY were the best predictors of baseline REE, whereas age, 
FFM, and FM predicted the greatest amount of variance in REE after intervention. These same 
predictors, except for leptin, were significantly related to TEE at baseline and after the 
intervention, whereas only PYY was a significant predictor of PAEE at both baseline and after 
the intervention. Additionally, ΔFM and Δ leptin were strong contributors to ΔREE. However, Δ 
leptin and ΔPYY were not significant predictors of the greater-than-predicted decrease in REE 
after weight loss. 
 
The reduction in leptin adjusted for changes in FM after both interventions in the present study 
are similar to those previously reported by Doucet et al (18) after weight loss in obese men and 
women as well as that reported by Rosenbaum et al (30) after weight loss in normal-weight and 
obese women. Additionally, baseline leptin was negatively associated with Δweight and ΔFFM, 
which contrasts other studies that reported negative associations between baseline leptin with 
Δweight and ΔFM (31, 32). It is possible that interindividual factors, which impact leptin levels 
(eg, age, menopausal status, sex), may in part explain these differences in results. 
 
The combination of Δ leptin and ΔFM were the best predictors of ΔREE during weight loss 
(∼27% of the variance explained). These results extend previous findings (18), indicating that Δ 
leptin was the best predictor of REE changes in men, whereas ΔFM was the strongest predictor 
of ΔREE in women. These significant associations may also in part explain the decrease in REE, 
which occurred in both intervention groups because all participants had similar decreases in 
weight, independently of the intervention. 
 
The present study also noted greater predicted vs measured REE after weight loss, which concurs 
with previous findings (5, 7–14). This metabolic adaptation was affected by the degree of caloric 
restriction, in which participants with the greatest prescribed caloric restriction saw greater 
decreases in their measured vs predicted REE after the intervention. However, compliance to the 
prescribed caloric restriction and energy imbalance, which were calculated based on actual 
changes in energy reserves, were not associated with this greater-than-predicted decrease in 
REE. Doucet et al (8) noted that Δ leptin was significantly related to the difference between 
measured and net predicted exercise EE (ie, difference between sitting and exercise EE) in men 
after weight loss, whereas the present study noted no such association between Δ leptin and 
differences in postintervention measured vs predicted REE. A recent study by Knuth et al (14) 
reported no significant associations between residual leptin changes and the degree of metabolic 
adaptation after weight loss, despite noting significant correlations between the degree of 
metabolic adaptation with Δ leptin and the degree of average energy imbalance. It may be 
hypothesized that changes in leptin may in part contribute to changes in REE during weight loss 
but that other factors, including the degree of caloric restriction and energy imbalance, may also 
be partly responsible for explaining the greater-than-predicted changes in REE (3, 5, 14). 
 
Even though Δ leptin was found to be a significant predictor of ΔREE during weight loss, our 
results indicate that age, FFM, and PYY, in addition to leptin, significantly predicted REE at 
baseline, whereas FFM, FM, and age better predicted the variance observed in REE after weight 
loss. Additionally, leptin was not associated with TEE and PAEE at baseline and after the 
intervention. These results indicate that the short-term depression of REE during the dynamic 
phase of weight loss may be in part mediated by changes in leptin, whereas weight maintenance 
may be more so influenced by the depletion of energy stores and age. However, much of the 
variance, especially for TEE and PAEE, remains unexplained by the predictors measured in the 
present study. Hence, more studies are needed to evaluate other potential factors that could be 
related to different EE components at baseline, during and after weight loss. 
 
Factors other than those measured in the present study have been shown to modulate REE 
changes during weight loss. One such example is the effect of sympathetic nervous system 
activity and catecholamine changes on decreased REE and TEE after weight loss (17, 33, 34). 
Decreases in 24-hour noradrenalin excretion during a 3-week low-energy diet have been 
previously reported (34). This decrease may play an important role in weight loss as the use of 
sympathomimetics in combination with a weight-loss regimen yielded greater decreases in FM in 
addition to lower depressions of REE after the intervention (35). Rosenbaum et al (17) also noted 
that changes in catecholamine excretion explained approximately 25%–40% of changes in TEE 
and REE after weight loss and that significant reductions in T3 release occurred in response to 
weight loss. Additionally, Johannsen et al (12) noted a significant association between changes 
in TSH levels and the degree of metabolic adaptation associated with weight loss (ie, greater 
increases in TSH were associated with the smallest metabolic adaptations to weight loss). Hence, 
the effects of the sympathetic nervous system and thyroid hormones, in addition to leptin, should 
be taken into consideration when aiming to determine the factors involved in predicting changes 
of REE and TEE during weight loss. Another factor that may influence EE changes during 
weight loss is the potential decrease seen in REE as a result of the decreased size and energy 
metabolism of individual organs (36). However, it seems that after accounting for changes in 
FM, FFM, and organ EE, approximately 40% of the decrease in REE is not accounted for by 
organ and tissue mass (37). Other biological factors thus most likely contribute to the greater-
than-predicted changes in REE and TEE that result from weight loss, which may be the result of 
an adaptive response of physiological mediators that have adjusted to feast-famine cycles 
throughout human evolution (38). 
 
PYY was found to be a significant, negative predictor of REE at baseline and was the only 
endocrine factor measured in the present study that was correlated with TEE and PAEE at 
baseline and after the intervention. There is evidence to show that PYY exerts influence over 
various components of EE (21–24). More specifically, cross-sectional analyses showed that 
fasting PYY is negatively associated with REE in normal-weight and obese men and women 
(24), whereas Hill et al (23) observed a positive association between 24-hour mean PYY and 
REE in normal-weight, premenopausal women. However, neither of these studies reported 
significant associations between PYY and TEE (23, 24). Doucet et al (22) reported that total 
postprandial PYY was a correlate of postprandial EE in weight-stable, premenopausal women. 
Furthermore, the infusion of PYY 3–36 showed a tendency (P = .06) to increase TEE, compared 
with the infusion of a saline solution or PYY 1–36 in weight-stable men (21). There is a 
possibility that if PYY does affect REE and TEE, these changes may be partially due to the 
action of PYY on neuropeptide Y (39). PYY 3–36 binds to specific receptors, including Y5 
receptors in neuropeptide Y, located within the nuclei of the hypothalamus (40). The 
intracervical infusion of Y5 agonists in rats has been associated with reductions in oxygen 
consumption and TEE (39). Taken together, results from the present study add to those 
previously reported, suggesting that PYY is a predictor of REE, TEE, and PAEE prior to and 
after weight loss. However, more work is needed in humans to garner an understanding as to 
how PYY affects these components of EE. 
 
The present findings are limited to a sample of postmenopausal women, which limits 
generalizability to other populations. Only fasting PYY and fasting leptin concentrations were 
measured in our participants. The EE measurements prior to and after the intervention may not 
account for the actual energy cost of exercising, which may translate into slight increases in REE 
due to increased energy requirements for recovery (41). The compliance equation used assumes a 
linear decrease in TEE from baseline to postintervention, which may not be the case. 
Furthermore, a potential drift in weight of ±2 kg during the time of measurements could 
compromise certain metabolic measurements, including REE. However, studies (5, 13) have 
shown that metabolic adaptation seems to persist after weight loss and this even when 
participants regained the weight lost. Hence, participants in the present study would most likely 
still be displaying lower-than-predicted REE values, even if weight may have fluctuated during 
this period. Lastly, the correlations computed between different variables cannot infer causality. 
 
In conclusion, leptin and PYY were significant correlates only of baseline REE, whereas age and 
bodily tissues explained most of the variance in REE after the intervention. PYY was 
significantly associated with TEE and PAEE at baseline and after the intervention. ΔFM and Δ 
leptin were strongly correlated with ΔREE. However, Δ leptin and ΔPYY were not significant 
predictors of the greater-than-predicted decrease in REE after the intervention. These novel 
results suggest that we cannot exclude the possibility that other biological factors in addition to 
leptin may account for the greater-than-predicted decreases in REE observed after weight loss. 
More studies are needed to explore different underlying biological factors, which may contribute 
to the variance in different EE components at baseline, during and after weight loss as well as 
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